Contrasting ALT5 Sigma (NASDAQ:ALTS) and Resolute Holdings Management (NYSE:RHLD)

Resolute Holdings Management (NYSE:RHLD) and ALT5 Sigma (NASDAQ:ALTS) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Profitability

This table compares Resolute Holdings Management and ALT5 Sigma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Resolute Holdings Management	23.82%	-646.55%	9.94%
ALT5 Sigma	-74.89%	-179.27%	-16.28%

Earnings & Valuation

This table compares Resolute Holdings Management and ALT5 Sigma”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Resolute Holdings Management	$420.57 million	3.68	$110.26 million	($0.49)	-370.34
ALT5 Sigma	$12.53 million	15.56	-$6.24 million	N/A	N/A

Resolute Holdings Management has higher revenue and earnings than ALT5 Sigma.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Resolute Holdings Management and ALT5 Sigma, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Resolute Holdings Management	1	0	0	0	1.00
ALT5 Sigma	1	0	0	0	1.00

Insider and Institutional Ownership

6.3% of ALT5 Sigma shares are held by institutional investors. 50.8% of Resolute Holdings Management shares are held by company insiders. Comparatively, 0.7% of ALT5 Sigma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Resolute Holdings Management beats ALT5 Sigma on 5 of the 8 factors compared between the two stocks.

About Resolute Holdings Management

Resolute Holdings Management, Inc. operates as an alternative asset management platform company. The company was incorporated in 2024 and is based in New York, New York.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.